Product Innovation Times
SEE OTHER BRANDS

Get your daily news on consumer products

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Product Innovation Times.

Celcuity Provides Update on Status of the PIK3CA Mutated Cohort of Phase 3 VIKTORIA-1 Trial and Releases Additional Data Analysis From Phase 1b Clinical Trial
Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025
Innovate Media Canada Challenges the Myth That SEO Is Dead — and Redefines What Optimization Means in 2025
Trial Attorney Clint Zalas of South Bend Explains Essential Steps Before Talking to an Insurance Company for HelloNation
Big Fundraising Ideas Solidifies Position as the Best Company for School Fundraising
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages RCI Hospitality Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – RICK
Arman Gabay Real Estate Scholarship Unveils New Initiative for Undergraduate Innovators
Mountain America Credit Union Named 2026’s Top Credit Union in the Nation for Innovation by Money.com
Shefali Sanghi Joins Thynk Ventures as Partner, Expanding Focus on AI, Data, and Consumer Innovation
Detergent Refill Systems Market Set for Strong Growth Amid Sustainability and Innovation Trends
Repliers Names Industry Veteran Rhett Damon CEO to Accelerate U.S. Growth and Innovation
Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025
Ducon Infratechnologies Ltd (NSE: DUCON) — CMD’s Strategic Update Underscores Strong Momentum, Innovation Push & Investor Upside
Neeraj Jha Positions AJGAR.com as a Rising Name in India’s Fashion E-Retail Industry
Terra Innovatum Global Files New Investor Presentation Updating Timeline for First-of-A-Kind SOLO™ Deployment in 2027 from 2028
Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week
Evaxion reports 75% Objective Response Rate in phase 2 trial with AI-designed personalized cancer vaccine EVX-01
Incubyte Accelerates AI Adoption with a Culture of Craft and Conscious Innovation
INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend
Bioplates by Alex Hell Wins Silver in A' Design Award for Sustainable Products

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions